Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$10.36 - $11.74 $1.19 Million - $1.35 Million
-115,000 Reduced 10.02%
1,032,752 $10.9 Million
Q1 2024

May 09, 2024

BUY
$9.87 - $11.8 $11.3 Million - $13.5 Million
1,147,752 New
1,147,752 $12.1 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.15B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Tiff Advisory Services Inc Portfolio

Follow Tiff Advisory Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiff Advisory Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tiff Advisory Services Inc with notifications on news.